T2 Biosystems (TTOO) closed the most recent trading day at $1.66, moving +1.84% from the previous trading session. This change outpaced the S&P 500's 0.77% gain on the day. Elsewhere, the Dow gained 0.44%, while the tech-heavy Nasdaq added 1.49%. Heading into today, shares of the diagnostics company had gained 16.43% over the past month, outpacing the Medical sector's gain of 4.73% and the S&P 500's gain of 5.03% in that time. TTOO will be looking to display strength as it nears its next earnings release, which is expected to be August 11, 2020. The company is expected to report EPS of -$0.18, up 48.57% from the prior-year quarter. Investors should also note any recent changes to analyst estimates for TTOO. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Research indicates that these estimate revisions are directly correlated with near-term share price momentum.